Regenerative therapy research receives boost following construction of new research centre

The opening in 2011 of a new building for the Centre for Regenerative Therapies Dresden has allowed research teams working in the field of bio-medical science to work alongside each under the same roof, increasing the possibility of co-operation between the scientists.

Additional tools

Print  
The main aim of the new centre is to carry out research into the potential of the human body to heal itself and to develop new regenerative therapies The main aim of the new centre is to carry out research into the potential of the human body to heal itself and to develop new regenerative therapies

The Centre for Regenerative Therapies Dresden (CRTD) was, as part of the Technische Universität Dresden, founded in 2006 and has been designated as a cluster of research excellence by the German Research Foundation (DFG). The Centre’s main aim is to carry out research into the potential of the human body to heal itself and to develop new regenerative therapies. This work includes using animal models to develop therapies for so far incurable diseases. The centre’s research focuses on haematology, immunology, diabetes, neurodegenerative diseases, bone replacement and, to some extent, cardiovascular diseases.

Strengthening Saxony as a centre for bio-medical research

The director of the CRTD, Professor Michael Brand, said that the new facility was a welcome addition to Dresden’s lively international research community known as Biopolis. “Now, for the first time, all fifteen CRTD research groups are able to research and teach at the highest level under one roof within their own organisation,” the professor said. In addition, the new research centre facilitates interdisciplinary co-operation. A further aim of the project has been to enhance the reputation of Saxony as a centre for bio-medical research.

The CRTD currently employs more than 270 people, 180 of whom are scientists. The centre is involved in an interdisciplinary research network of over 80 laboratories in seven different institutions in Dresden. Eighteen commercial partners support the network and this enables the speedy transfer of research results into clinical applications.

“Top researchers need top research conditions. As of today, these should be in place, further increasing the attractiveness of our biotechnology site,” said Stanislaw Tillich, Minister President of the German region of Saxony, at the inauguration ceremony. “It is expected that the most significant improvements to our living conditions in future will be in the area of healthcare. Biomedicine has now developed into a successful branch of research and economics.”


Total and EU funding


The “New construction for the Research Centre for Regenerative Therapies – Excellence Cluster (CRTD)” received a contribution of EUR 7 500 000 from the EU’s European Regional Development Fund’s 2007 to 2013 programming period. The new CRTD building had a total budget of EUR 48 600 000. The national contribution was EUR 41 000 000, of which EUR 26 000 000 came from the Free State of Saxony and the Technische Universität Dresden and EUR 15 000 000 came from the federal government. The project is funded through the priority “Strengthening innovation, science and research” of the Operational Programme for Saxony 2007-2013.


Draft date

05/03/2013